Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07072819 · ClinicalTrials.gov registry record · NA

Pilot of Training on 988 and Narcan

A NA study of Suicide and Overdose Accidental, sponsored by RAND.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT07072819: Completed NA study of Suicide and Overdose Accidental, sponsored by RAND.

NCT07072819 is a NA study of Suicide and Overdose Accidental that has completed, run by RAND. The registered enrollment target is 27 participants, below the 6,990-participant average among 92 other Suicide trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07072819, a NA study of Suicide and Overdose Accidental, has completed, sponsored by RAND.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

This pilot study evaluates the acceptability, appropriateness, and feasibility of a new crisis response training called Crisis Ready.

Primary Outcome

Participants' perspectives of the likability of the intervention. Scores range from 4 to 20, with higher scores indicating higher levels of acceptability.

Interventions

  • BEHAVIORAL Crisis Ready Training

Study Locations (1)

Maryland

  • Baltimore Crisis Response, Inc. - Baltimore

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2025-06-12
Est. Completion 2025-07-31
Phase NA
RAND

78 total trials

What the finished NCT07072819 record still lists

NCT07072819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 6,990-participant average among 92 other Suicide trials with a reported enrollment target (100% lower).

The record links to 4 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Crisis Ready Training is the first listed.

NCT07072819 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT07072819 about?

NCT07072819 is a clinical study titled "Pilot of Training on 988 and Narcan". This pilot study evaluates the acceptability, appropriateness, and feasibility of a new crisis response training called Crisis Ready.

What is the current status of trial NCT07072819?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2025-06-12. Estimated completion is 2025-07-31.

What conditions does trial NCT07072819 study?

This clinical trial studies the following conditions: Suicide, Overdose Accidental, Crisis Response Plan, Overdose Antidote.

What interventions are being tested in trial NCT07072819?

The interventions under investigation include: Crisis Ready Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT07072819?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07072819 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07072819's enrollment target sits among peer trials

27 82nd of 92 higher than 11 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07072819, the US trial registry maintained by the National Library of Medicine. NCT07072819 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.